References
- Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. Semin Nephrol. 2002; 22:449–58.10.1053/snep.2002.35973
- Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009; 53:166–74.1910140010.1053/j.ajkd.2007.10.047
- Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol. 2009; 296:F1239–44.1914469110.1152/ajprenal.90521.2008
- Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004; 101:13368–73.10.1073/pnas.0403453101
- Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol. 2003; 23: 161–71.1270457610.1053/snep.2003.50015
- Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol. 2001; 281: F887–99.10.1152/ajprenal.00050.200111592947
- Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, et al. Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int. 2011; 79: 179–88.2092704210.1038/ki.2010.379
- Eddy AA, Lopez-Guisa JM, Okamura DM, Yamaguchi I.Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol. 2012; 27:1233–47.10.1007/s00467-011-1938-221695449
- Walkin L, Herrick SE, Summers A, Brenchley PE, Hoff CM, Korstanje R, et al. The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair. 2013; 6:18.2429483110.1186/1755-1536-6-18
- Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 2010; 78:1136–53.10.1038/ki.2010.287
- Seujange Y, Leelahavanichkul A, Yisarakun W, Khawsuk W, Meepool A, Phamonleatmongkol P, et al. Hibiscus sabdariffa Linnaeus aqueous extracts attenuate the progression of renal injury in 5/6 nephrectomy rats. Ren Fail. 2013; 35:118–25.2315771510.3109/0886022X.2012.741468
- Leelahavanichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG, Souza AC, et al. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol. 2012; 188:2749–58.10.4049/jimmunol.1003445
- Leelahavanichkul A, Huang Y, Hu X, Zhou H, Tsuji T, Chen R, et al. Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1. Kidney Int. 2011; 80:1198–211.10.1038/ki.2011.26121832986
- Leelahavanichkul A, Yasuda H, Doi K, Hu X, Zhou H, Yuen PS, et al. Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. Am J Physiol Renal Physiol. 2008; 295:F1825–35.10.1152/ajprenal.90442.200818922884
- Yasuda H, Leelahavanichkul A, Tsunoda S, Dear JW, Takahashi Y, Ito S, et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol. 2008; 294:F1050–8.10.1152/ajprenal.00461.200718305095
- Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006; 69:1471–6.1650149010.1038/sj.ki.5000273
- Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006; 70:1847–57.10.1038/sj.ki.500187417021608
- Fogelgren B, Yang S, Sharp IC, Huckstep OJ, Ma W, Somponpun SJ, et al. Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice. Am J Physiol Renal Physiol. 2009; 296:F1166–78.10.1152/ajprenal.90550.2008
- Miner JH, Sanes JR. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome. J Cell Biol. 1996; 135:1403–13.10.1083/jcb.135.5.14038947561
- Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol. 2009; 296: F213–29.10.1152/ajprenal.90421.200818784259
- Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006; 5: 1760–71.1683757610.1074/mcp.R600004-MCP200
- Knepper MA, Pisitkun T. Exosomes in urine: who would have thought? Kidney Int. 2007; 72:1043–5.
- Zhou H, Kajiyama H, Tsuji T, Hu X, Leelahavanichkul A, Vento S, et al. Urinary exosomal Wilms’ tumor-1 as a potential biomarker for podocyte injury. Am J Physiol Renal Physiol. 2013; 305:F553–9.10.1152/ajprenal.00056.201323761678
- Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008; 74:613–21.10.1038/ki.2008.20618509321
- Dear JW, Street JM, Bailey MA. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics. 2013; 13:1572–80.2312943410.1002/pmic.201200285